NAS:GEHC (USA)
Â
Common Stock
$
77.92
-0.9 (-1.14%)
11:09 PM EST
Business Description
GE HealthCare Technologies Inc
NAICS : 923120
SIC : 7372
ISIN : US36266G1076
Share Class Description:
GEHC: Common StockCompare
Compare
Traded in other countries / regions
GEHC.USAL0T.GermanyGEHC.Mexico IPO Date
2022-12-15Description
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 1.31 | |||||
Debt-to-EBITDA | 2.79 | |||||
Interest Coverage | 4.44 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 1.86 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.2 | |||||
3-Year EBITDA Growth Rate | 0.8 | |||||
3-Year EPS without NRI Growth Rate | -3.8 | |||||
3-Year FCF Growth Rate | 6 | |||||
3-Year Book Growth Rate | -21.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.46 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.07 | |||||
9-Day RSI | 47.17 | |||||
14-Day RSI | 46.32 | |||||
6-1 Month Momentum % | 1.56 | |||||
12-1 Month Momentum % | 2.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 66.91 | |||||
Days Sales Outstanding | 59.84 | |||||
Days Payable | 91.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.15 | |||||
Dividend Payout Ratio | 0.03 | |||||
Forward Dividend Yield % | 0.15 | |||||
5-Year Yield-on-Cost % | 0.15 | |||||
Shareholder Yield % | -10.26 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.69 | |||||
Operating Margin % | 12.39 | |||||
Net Margin % | 8.05 | |||||
FCF Margin % | 8.53 | |||||
ROE % | 22.14 | |||||
ROA % | 4.85 | |||||
ROIC % | 6.01 | |||||
ROC (Joel Greenblatt) % | 119.78 | |||||
ROCE % | 11.89 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.78 | |||||
Forward PE Ratio | 18.12 | |||||
PE Ratio without NRI | 22.65 | |||||
PS Ratio | 1.83 | |||||
PB Ratio | 4.8 | |||||
Price-to-Free-Cash-Flow | 21.47 | |||||
Price-to-Operating-Cash-Flow | 17.4 | |||||
EV-to-EBIT | 14.87 | |||||
EV-to-Forward-EBIT | 13.51 | |||||
EV-to-EBITDA | 12.29 | |||||
EV-to-Forward-EBITDA | 11.44 | |||||
EV-to-Revenue | 2.19 | |||||
EV-to-Forward-Revenue | 2.11 | |||||
EV-to-FCF | 25.67 | |||||
Earnings Yield (Greenblatt) % | 6.72 | |||||
FCF Yield % | 4.68 |